Search:


Companies > Clinical
print
Cleveland BioLabs (NASDAQ: CBLI) is developing new drugs to protect human tissues from injury caused by acute stresses such as radiation, chemotherapy and ischemias. The company is also leveraging its expertise in apoptosis to develop novel cancer therapeutics.


Funders:
Sunrise Equity Partners
Recent News

»  Minnesota, Ohio, Missouri Attract Most Midwest Health Care Investment

»  SPR Therapeutics Raises $2.2 Million

»  Philips Healthcare and Steris Announce Cleveland Expansions

»  Intelligent Mobile Support Receives Investment

»  ChanRx Raises Series A from Santé Ventures




Commercialized Products & Services


Syncro Blue Tube
One of the many health care innovations brought to market by client companies.
» View More




Exit Companies



Since 2002, 21 Cleveland-area health care companies have had successful exits.

» View More




Cleveland Medical Mart & Convention Center



The world’s only convention facility created for the health care industry.
» View More
 
Copyright © 2012 BioEnterprise   | Home | Disclaimer | Sitemap | Contact Us BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999